Simon Leboube (@sleboube) profile picture

Simon Leboube

@sleboube

Cardiologist @CHUdeLyon PhD student in IRIS Team @CarMeN_lab_lyon

 Lyon
Joined June 2011
  • Tweets16
  • Following43
  • Followers37
Glad to be back at #aha2022 in Chicago with my colleagues @sleboube @PaillardMel @GomezLudovik @CHUdeLyon @HCL_research @LaboratoryIris
Image from thomas.bochaton (@BochatonThomas)
2
4
25
Simon Leboube retweeted
LDLC ASVEL (@LDLCASVEL) profile picture
LDLC ASVEL
@LDLCASVEL6 Feb 2022
🙏 Dans le cadre des Journées de l’Avenir organisées dans tous les clubs de LNB, Gaëtan Muller, Alain Béral, Président de la @LNBofficiel et Marion Lelouvier, Présidente de la @FondationAvenir, remettent le chèque à Mélanie Paillard, chercheuse à l’hôpital Lyon Sud ! #LDLCASVEL
Image from LDLC ASVEL (@LDLCASVEL)
2
5
2
31
Félicitations au Professeur Marco Vola du GHE cardiologie des Hospices Civils de Lyon pour l’obtention de son projets RHU (Recherche Hospitalo-Universitaire en santé) : « ICELAND » @HCL_research @CarMeN_lab_Lyon @InsermAuRA @CHUdeLyon
4
11
les Journées de l'Avenir ! L'équipe Lyonnaise @LaboratoryIris a été sélectionnée pour ses recherches dans le domaine cardiovasculaire par la LNB @LNBofficiel et à la @FondationAvenir pour faire avancer la recherche médicale journeesdelavenir.fr merci de diffuser
2
6
Simon Leboube retweeted
Ahmad Hayek (@AhmadHayek0) profile picture
Ahmad Hayek@AhmadHayek027 Oct 2021
From @jaccjournals jacc.org/doi/10.1016/j.jacc.… Check our latest article! @BochatonThomas @mewton_nathan @CHUdeLyon @alexPaccalet
Prognosis After Percutaneous Foramen Ovale Closure Among Patients With Platypnea-Orthodeoxia...

Prognosis After Percutaneous Foramen Ovale Closure Among Patients With Platypnea-Orthodeoxia...

jacc.org
3
13
Our latest article: Prognosis value of serum soluble ST2 level in acute ischemic stroke and STEMI patients in the era of mechanical rep… pubmed.ncbi.nlm.nih.gov/3469… @alexPaccalet @crola_da @mewton_nathan @sleboube
Prognosis value of serum soluble ST2 level in acute ischemic stroke and STEMI patients in the era...

Prognosis value of serum soluble ST2 level in acute ischemic stroke and STEMI patients in the era...

The study highlights that sST2 levels at 24 h are associated with an increased risk to adverse clinical events in both diseases.

pubmed.ncbi.nlm.nih.gov
4
1
14
After his excellent thesis defense, Alexandre Paccalet is now in Nahrendorf laboratory (Harvard University, Boston) for his post-doctoral fellowship, Good luck in your future research Alex! @LaboratoryIris @CarMeN_lab_Lyon @MatthiasNahrend @alexPaccalet @HCL_research @Inserm
Image from IRIS Team Carmen Laboratory (@LaboratoryIris)
1
4
13
Serum soluble Tumor Necrosis Factor Receptor (sTNFR) 1 and 2 are early prognosis markers after STEMI frontiersin.org/article/10.3… @alexPaccalet @crola_da @sleboube @mewton_nathan @CHUdeLyon @Inserm @LaboratoryIris

Frontiers | Serum Soluble Tumor Necrosis Factor Receptors 1 and 2 Are Early Prognosis Markers After...

Background: Inflammation following STEMI playing dual role, beneficial and deleterious, there is a need to find new biomarkers of STEMI severity.Objective: W...

frontiersin.org
5
12
Simon Leboube retweeted
Ahmad Hayek (@AhmadHayek0) profile picture
Ahmad Hayek@AhmadHayek010 Aug 2021
Transcatheter mitral valve repair to treat postmyocardial infarction papillary muscle rupture Hayek A, Grinberg D, Derimay F, Bochaton T - J Cardiovasc Echography jcecho.org/article.asp?issn=… @BochatonThomas @dnlgrinberg @CHUdeLyon
3
10
Simon Leboube retweeted
Ahmad Hayek (@AhmadHayek0) profile picture
Ahmad Hayek@AhmadHayek06 Jun 2021
Acute pulmonary embolism and thrombus entrapped in the patent foramen ovale in a patient with COVID-19 Hayek A, Flagiello M, Aubry M, Bochaton T - J Cardiovasc Echography jcecho.org/article.asp?issn=…
2
2
8
📣Great news for our PhD student @alexPaccalet, who recently got supported by @Servier Institute for his post-doctoral project in @Harvard! 📝 @CarMeN_lab_Lyon @HCL_research @InsermAuRA
4
10
Soluble C-Met is a biomarker of clinical outcomes after STEMI From @jaccjournals jacc.org/doi/10.1016/j.jacc.… @BochatonThomas @alexPaccalet @crola_da @mewton_nathan @CHUdeLyon @LaboratoryIris @fedecardio @AngoulvantD
Soluble C-Met as a Biomarker of Clinical Outcomes After STEMI:

Soluble C-Met as a Biomarker of Clinical Outcomes After STEMI:

jacc.org
1
3
Our Phd student have something to say about myocardial ischemia-reperfusion injury and diabetes!! !! 🫀💊 frontiersin.org/article/10.3… @MayaDia1 @alexPaccalet @crola_da @BochatonThomas @CarMeN_lab_Lyon @FrontiersIn @InsermAuRA @HCL_research #cardiotwitter
3
1
5
Our last article: Kinetics and prognostic value of soluble VCAM‐1 in ST‐segment elevation myocardial infarction patients onlinelibrary.wiley.com/doi/… @AhmadHayek0 @mewton_nathan @crola_da @alexPaccalet @FabriceIvanes @CHUdeLyon @CarMeN_lab_Lyon @Inserm
3
6
Hey #cardiotwitter 📣 RIFIFI study is out 📣 Myocardial hemorrhage present a strongest relationship with inflammatory biomarkers release compare to persistant MVO or edema in STEMI patients 🫀🔥 @BochatonThomas @mewton_nathan @CarMeN_lab_Lyon @CHUdeLyon – at Villeurbanne, France
thomas.bochaton (@BochatonThomas) profile picturethomas.bochaton@BochatonThomas28 Jan 2021
#PLOSONE: Association of myocardial hemorrhage and persistent microvascular obstruction with circulating infl ... dx.plos.org/10.1371/journal.… @crola_da @alexPaccalet @mewton_nathan @CarMeN_lab_Lyon
2
3
Hsp-70 as a biomarker of Clinical outcomes after STEMI. @JACCJournals @BochatonThomas @ovizem @CHUdeLyon @mewton_nathan onlinejacc.org/content/75/1/……. – at Bron, France
Image from Paccalet Alexandre (@alexPaccalet)
1
4
4
Load more